
Pediatrix Medical Group
(NYSE) MD
Pediatrix Medical Group Financials at a Glance
Market Cap
$1.93B
Revenue (TTM)
$1.93B
Net Income (TTM)
$174.22M
EPS (TTM)
$2.05
P/E Ratio
11.46
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$23.45
Volume
798,764
Open
$23.04
Price
$23.45
Volume
798,764
Open
$23.04
Previous Close
$23.51
Daily Range
$22.91 - $23.74
52-Week Range
$11.84 - $24.99
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$23.45
Volume
798,764
Open
$23.04
Previous Close
$23.51
Daily Range
$22.91 - $23.74
52-Week Range
$11.84 - $24.99
MD News

Why Mednax Is Crashing 21.2% Today
MD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pediatrix Medical Group
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
6,575
CEO
Mark S. Ordan, MBA
Website
www.pediatrix.comHeadquarters
Sunrise, FL 33323, US
MD Financials
Key Financial Metrics (TTM)
Gross Margin
26%
Operating Margin
12%
Net Income Margin
9%
Return on Equity
21%
Return on Capital
14%
Return on Assets
8%
Earnings Yield
8.73%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.93B
Shares Outstanding
82.12M
Volume
798.76K
Avg. Volume
901.13K
Financials (TTM)
Gross Profit
$471.88M
Operating Income
$231.09M
EBITDA
$274.22M
Operating Cash Flow
$271.09M
Capital Expenditure
$18.46M
Free Cash Flow
$252.63M
Cash & ST Invst.
$499.72M
Total Debt
$660.30M
Pediatrix Medical Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$476.20M
+3.9%
Gross Profit
$112.96M
+10.1%
Gross Margin
23.72%
N/A
Market Cap
$1.93B
N/A
Market Cap/Employee
$468.61K
N/A
Employees
4,120
N/A
Net Income
$29.57M
+42.6%
EBITDA
$53.23M
+25.0%
Quarterly Fundamentals
Net Cash
$300.74M
+31.0%
Accounts Receivable
$236.99M
-6.3%
Inventory
$0.00
N/A
Long Term Debt
$425.41M
-31.5%
Short Term Debt
$204.31M
+495.6%
Return on Assets
8.42%
N/A
Return on Invested Capital
14.08%
N/A
Free Cash Flow
$135.75M
-12.4%
Operating Cash Flow
$129.50M
-10.2%






